###begin article-title 0
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
The kinase MSK1 is required for induction of c-fos by lysophosphatidic acid in mouse embryonic stem cells
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
The regulation of the immediate-early gene c-fos serves as a paradigm for signal-activated gene induction. Lysophosphatidic acid is a potent serum-borne mitogen able to induce c-fos.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 468 472 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Analysing the signalling events following stimulation of mouse embryonic stem cells with serum and lysophosphatidic acid, we show that the extracellular signal-regulated kinase (ERK) pathway is involved in mediating c-fos induction. We demonstrate that the ERK-activated kinase MSK1 is required for full c-fos promoter activation, as well as for the phosphorylation of cAMP-responsive element (CRE) binding proteins. We propose that MSK1 contributes to ERK-mediated c-fos promoter activation by targeting CRE binding proteins.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 320 323 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
These results show that MSK1 is an important ERK-activated mediator of mitogen-stimulated c-fos induction. In addition, they indicate that MSK1 could act through CRE binding proteins to achieve c-fos promoter activation. Thus, they further our understanding of the complex regulation of the model immediate-early gene c-fos.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 589 592 589 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
Lysophosphatidic acid (LPA) is an intercellular mediator involved in inflammation and wound healing [1]. It is released by activated platelets and leukocytes, and is one of the most potent mitogens found in serum. LPA acts through G-protein-coupled receptors to activate a number of intracellular signalling pathways including mitogen-activated protein (MAP) kinase cascades and Rho signalling. This leads to cellular responses such as proliferation, differentiation and suppression of apoptosis. One way in which these effects are mediated is induction of immediate-early genes such as c-fos.
###end p 8
###begin p 9
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sis</italic>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
The c-fos promoter has been extensively studied as a model for signal-activated gene induction [2,3]. It contains several regulatory elements, namely a serum response element (SRE), a cAMP-responsive element (CRE), a sis-inducible element, and an AP-1-like site, which serve to integrate input from a host of signalling pathways. These promoter elements are strongly interdependent. Mutation of one of them inhibits c-fos activation through any of the other elements, suggesting that they are connected by protein complexes [4].
###end p 9
###begin p 10
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 547 548 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 625 629 625 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 824 825 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 898 899 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
The c-fos SRE is constitutively occupied by the transcription factor serum response factor (SRF) [5]. Its presence allows members of the Ets family ternary complex factors (TCFs) to bind to the SRE [6]. A well understood mechanism underlying c-fos induction is phosphorylation of TCFs by MAP kinases, leading to transactivation [2]. SRF bound to SRE reporter genes can also be activated independently of TCFs by at least two signalling pathways, one involving the small GTPase Rho, while the other is regulated by phosphatidylinositol 3-kinase [7,8]. However, how these pathways contribute to the control of the endogenous c-fos gene is not clear. In addition, SRF is phosphorylated in a signal-regulated manner by several kinases, including MAP kinase-activated protein kinase-1 (MAPKAP-K1, also called RSK) and MAPKAP-K2 [9,10]. SRF phosphorylation has been correlated with enhanced DNA binding [9,11], but so far there is no direct evidence for a functional role of SRF phosphorylation.
###end p 10
###begin p 11
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
The CRE is bound by CRE binding protein family members, including CREB and ATF1. Upon phosphorylation, they recruit the co-activator CREB binding protein (CBP), thus effecting transactivation. Phosphorylation of CREB can be induced by several distinct pathways. For instance, in response to elevated intracellular cAMP levels, CREB is phosphorylated by protein kinase A. Growth factors and cellular stresses induce CREB phosphorylation by activating downstream targets of the classical extracellular signal-regulated kinase (ERK) pathway and the stress-activated p38 pathway, respectively [12]. MAPKAP-K1b/RSK2 was initially thought to be the major growth factor-regulated CREB kinase [13,14], but recent evidence indicates that mitogen- and stress-activated kinases (MSKs) play this role [15-17].
###end p 11
###begin p 12
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 455 459 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Signal-dependent changes in chromatin structure as part of the nucleosomal response constitute an additional level of regulation [18]. Stimulation rapidly induces histone phosphorylation and acetylation at the loci of immediate-early genes [19]. Histone kinase activity has been shown for both MAPKAP-K1b/RSK2 and MSK1, while CBP possesses histone acetyltransferase activity [20-22]. Therefore, these molecules might play a dual role by contributing to c-fos induction at the level of chromatin remodeling as well as promoter activation.
###end p 12
###begin p 13
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Transfection experiments have shown that LPA targets the SRE to activate the c-fos promoter. This was proposed to occur through a Rho-dependent pathway, independently of TCFs and MAP kinases [7]. However, a more recent study concluded that induction of the endogenous c-fos gene by LPA requires the ERK pathway, but not Rho signalling [23]. In addition, some c-fos induction by LPA remains in cells that lack SRF and thereby signalling to the SRE [24], indicating that other promoter elements may contribute to c-fos induction.
###end p 13
###begin p 14
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Here, we analyse the signalling events leading from LPA stimulation to c-fos promoter activation. We confirm that regulation of the endogenous c-fos gene involves the ERK pathway and provide direct genetic evidence for a role of MSK1 in this process. Furthermore, we suggest phosphorylation of CRE binding proteins by MSK1 as a mechanism to link the ERK pathway to the c-fos promoter, thus allowing for SRF-independent c-fos induction.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
The ERK pathway is involved in c-fos induction by serum and LPA
###end title 16
###begin p 17
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 88 92 <span type="species:ncbi:9913">calf</span>
Serum-starved wild type (WT) mouse embryonic stem (ES) cells were stimulated with fetal calf serum (FCS) or LPA. Activation of the major MAP kinases ERK1/ERK2, JNK1/JNK2, and p38 was determined by immunoblotting with phospho-specific antibodies against their T-X-Y activation motifs (Figure 1). ERK1/ERK2 phosphorylation was rapidly induced by both stimuli, followed by a slow decline. Induction of JNK1/JNK2 phosphorylation showed a delayed onset and was less pronounced. Induction of p38 phosphorylation was barely detectable.
###end p 17
###begin p 18
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MAP kinase activation in WT ES cells. </bold>
MAP kinase activation in WT ES cells. WT ES cells were serum-starved for 36 h and stimulated with 15% FCS or 20 muM LPA for the times indicated. Cell lysates were electrophoresed and immunoblotted with antibodies recognising the phosphorylated forms of ERK1/ERK2, JNK1/JNK2 and p38 (p-ERK1/2, p-JNK1/2 and p-p38). Antibodies against total ERK1/ERK2 and p38 served as loading controls.
###end p 18
###begin p 19
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 783 787 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 938 942 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1038 1042 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1070 1075 <span type="species:ncbi:10090">mouse</span>
Given its rapid activation, the ERK pathway could be involved in c-fos induction, which causes an increase of c-fos mRNA within 10 min of serum stimulation [24]. To test this, WT ES cells were stimulated with FCS and LPA in the absence or presence of PD98059, an inhibitor of the ERK pathway [25]. Accumulation of c-fos mRNA after 30 min of stimulation was measured by quantitative RT-PCR (Figure 2a). Induction of c-fos by both stimuli was reduced in the presence of PD98059. Figure 2b shows that PD98059 inhibited ERK activation. It should be noted, however, that PD98059 did not completely block ERK activation in this cell type (data not shown), so that our data may in fact underestimate the importance of the ERK pathway. To further corroborate that the ERK pathway mediates c-fos induction by FCS and LPA, Ro318220 was used to inhibit MAPKAP-K1/RSK and MSK1 [15,26], two downstream targets of ERK1/ERK2 (Figure 2c). Induction of c-fos by both stimuli was strongly inhibited by Ro318220. Therefore, the ERK pathway is involved in c-fos induction by FCS and LPA in mouse ES cells. In addition, the inhibitory effect of Ro318220 suggests that signalling through the ERK pathway involves MAPKAP-K1 or MSK1, or both kinases.
###end p 19
###begin p 20
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Induction of c-<italic>fos </italic>in WT ES cells. </bold>
###xml 35 37 35 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 305 309 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 662 666 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 731 733 721 723 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 869 870 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 872 874 862 864 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
Induction of c-fos in WT ES cells. A - Cells were serum-starved for 36 h and incubated with 25 muM PD98059 during the last hour of starvation where indicated. Cells were stimulated with 15% FCS or 20 muM LPA for 30 min, followed by quantitative RT-PCR. Based on relative mRNA levels, fold inductions of c-fos were calculated from three independent experiments (FCS: 82.1 +/- 27.6, FCS + PD: 43.8 +/- 25.7, LPA: 63.1 +/- 43.5, LPA + PD: 39.7 +/- 25.2). To eliminate experiment-to-experiment variations in the induction levels and to more clearly show the effect of PD98059, induction without inhibitor was set to 100% for each individual experiment and percent c-fos induction was calculated for the samples treated with inhibitor. B - Cells were serum-starved and treated as in A. Stimulation was done for 10 min and ERK1/ERK2 phosphorylation was analysed as in Figure 1. C - Cells were serum-starved and treated as in A, except that PD98059 was replaced by 5 muM Ro318220. Fold inductions from three independent experiments were FCS: 76.2 +/- 42.0, FCS + Ro: 15.7 +/- 10.5, LPA: 67.9 +/- 20.3, LPA + Ro: 2.8 +/- 1.9. Representation of the data as in A.
###end p 20
###begin title 21
MSK1 is required for c-fos induction by serum and LPA
###end title 21
###begin p 22
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
To examine the potential function of MSK1 in c-fos induction, we first tested whether it can be activated by FCS and LPA in mouse ES cells. Either stimulus activated MSK1 in serum-starved wild type mouse ES cells, as judged by immunoprecipitation kinase assays (Figure 3). This activation was inhibited by PD98059, indicating that it required the ERK pathway.
###end p 22
###begin p 23
###xml 0 32 0 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MSK1 activation in WT ES cells. </bold>
MSK1 activation in WT ES cells. WT ES cells were serum-starved for 8 h and incubated with 25 muM PD98059 during the last hour of starvation where indicated. Cells were stimulated with 15% FCS or 20 muM LPA for 10 min and MSK1 activity was determined by immunoprecipitation kinase assays. Error bars represent S.E.M. of four points.
###end p 23
###begin p 24
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 226 236 226 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 531 541 531 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 626 630 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 650 660 650 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 744 749 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msk1 </italic>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 891 895 891 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Msk1(-/-) ES cells [16] allowed direct assessment of the role of MSK1 in c-fos induction. Figure 4a shows that c-fos induction as measured by quantitative RT-PCR was reduced by at least 50% for both stimuli in three different Msk1(-/-) ES cell lines. This was confirmed by RNase protection assays (data not shown). The reduced c-fos induction at 30 min of stimulation could be due to a weaker promoter activation or due to a delayed response. To distinguish between these explanations, induction kinetics of c-fos in wild type and Msk1(-/-) ES cells were measured by semi-quantitative RT-PCR (Figure 4b). The time-course of c-fos induction by LPA in Msk1(-/-) ES cells was identical to that in wild type cells, excluding that disruption of the msk1 gene leads to a delayed c-fos induction. Hence, our data constitute direct genetic evidence that MSK1 is required for the activation of the c-fos promoter.
###end p 24
###begin p 25
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 29 39 29 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Induction of c-<italic>fos </italic>in WT and <italic>Msk1(-/-) </italic>ES cells. </bold>
###xml 49 51 49 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 85 95 85 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 347 349 346 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 358 368 357 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 464 468 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 644 648 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Induction of c-fos in WT and Msk1(-/-) ES cells. A - WT ES cells and three different Msk1(-/-) ES cell lines (No. 2, No. 4 and No. 5) were serum-starved for 24 h and stimulated with 15% FCS or 20 muM LPA for 30 min, followed by quantitative RT-PCR. Based on relative mRNA levels, fold inductions were calculated from five independent experiments. B - WT and Msk1(-/-) ES cells were serum-starved overnight and stimulated with 20 muM LPA for the times indicated. C-fos mRNA was amplified by semi-quantitative RT-PCR. PCR products were separated on agarose gels and stained with ethidium bromide (EtBr). EtBr intensities were used to calculate c-fos induction.
###end p 25
###begin title 26
MSK1 is required for the induction of CREB phosphorylation by serum and LPA
###end title 26
###begin p 27
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 409 410 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 611 621 611 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
One mechanism of ERK-mediated c-fos induction by MSK1 could be phosphorylation of CREB bound to the CRE of the c-fos promoter. We therefore tested whether FCS or LPA could induce CREB phosphorylation in ES cells in an MSK1-dependent manner. In wild type ES cells, both stimuli induced phosphorylation of CREB and the closely related transcription factor ATF1 on serine 133 and serine 63, respectively (Figure 5). In contrast, this phosphorylation was greatly reduced in ES cells lacking MSK1, despite normal ERK activation in these cells. CREB and ATF1 expression has previously been shown to be unperturbed in Msk1(-/-) ES cells [16]. Hence, MSK1 is required for the phosphorylation of the CRE binding proteins CREB and ATF1 after stimulation with FCS and LPA.
###end p 27
###begin p 28
###xml 26 36 26 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CREB activation in WT and <italic>Msk1(-/-) </italic>ES cells. </bold>
###xml 53 63 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 130 131 130 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 148 149 147 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
CREB activation in WT and Msk1(-/-) ES cells. WT and Msk1(-/-) ES cells were serum-starved overnight and stimulated with 15% FCS (A) or 20 muM LPA (B) for the times indicated. Cell lysates were electrophoresed and immunoblotted with antibodies against the phosphorylated forms of CREB/ATF1 and ERK1/ERK2 (p-CREB, p-ATF1, p-ERK1/2). An antibody against total ERK1/ERK2 served as loading control.
###end p 28
###begin title 29
Induction of c-fos through the ERK pathway can occur in the absence of SRF
###end title 29
###begin p 30
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 382 391 382 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf(-/-) </italic>
###xml 471 480 471 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf(-/-) </italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 615 619 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1051 1055 1051 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1128 1132 1128 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1237 1241 1237 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
SRF is known to be required for c-fos induction through the ERK pathway, with TCF phosphorylation providing the link between ERK1/ERK2 and SRF [2]. Only a small induction remains in the absence of SRF [24]. ERK-dependent CRE activation through CREB phosphorylation by MSK1 could provide a mechanism for this residual induction. If this were the case, the residual induction seen in Srf(-/-) cells should still be sensitive to inhibition of the ERK pathway. To test this, Srf(-/-) ES cells [27] were used to measure c-fos induction in the absence or presence of PD98059 or Ro318220 (Figure 6). As observed before, c-fos induction was drastically reduced in these cells (data not shown). The residual activation elicited by LPA (about five fold as compared to more than 60 fold in wild type cells) was too small to reliably measure the effects of PD98059 and Ro318220. However, the residual response to FCS was sensitive to inhibition of the ERK pathway, showing that TCF phosphorylation is not the only mechanism by which this pathway contributes to c-fos induction. Therefore, downstream targets of ERK1/ERK2 can activate the c-fos promoter in the absence of SRF. MSK1 might be such a downstream target, linking the ERK pathway to the c-fos promoter by CREB phosphorylation and subsequent CRE activation.
###end p 30
###begin p 31
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf(-/-) </italic>
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Induction of c-<italic>fos </italic>in <italic>Srf(-/-) </italic>ES cells. </bold>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 399 400 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Induction of c-fos in Srf(-/-) ES cells. Cells were serum-starved, treated with PD98059 and Ro318220 as in Figure 2. Cells were stimulated with 15% FCS for 30 min, followed by quantitative RT-PCR. Fold inductions from three independent experiments with each inhibitor were FCS: 26.5 +/- 1.8, FCS + PD: 15.6 +/- 6.0 and FCS: 16.0 +/- 14.3, FCS + Ro: 1.8 +/- 1.2. Representation of the data as Figure 2.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
In this study, we show that the ERK pathway is involved in LPA signalling to the c-fos promoter in mouse ES cells. We demonstrate that MSK1 is necessary for full c-fos promoter activation as well as for phosphorylation of CRE binding proteins, and we provide evidence for SRF-independent c-fos induction through the ERK pathway.
###end p 33
###begin p 34
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
The activation profiles of MAP kinases show ERK1/ERK2 and JNK1/JNK2 activation by serum and LPA, while only a slight p38 activation could be detected (Figure 1). These results are consistent with previous reports for the serum stimulation of ES cells [28]. Our experiments do not address the role of JNK1/JNK2 in c-fos induction. However, since activation of a chromosomal SRE reporter gene by LPA has been found to require JNK-mediated histone hyperacetylation [29], JNK1/JNK2 may be involved in c-fos regulation at the level of chromatin remodelling.
###end p 34
###begin p 35
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 305 309 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 480 484 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 572 581 572 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf(-/-) </italic>
###xml 671 672 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
The kinetics of ERK1/ERK2 activation and c-fos induction, as well as the reduced c-fos induction in the presence of the ERK pathway inhibitors PD98059 and Ro318220 are consistent with a role of ERK1/ERK2 in c-fos induction by serum and LPA (Figure 1 and 2). A major mechanism by which ERK1/ERK2 mediate c-fos induction, is phosphorylation of TCFs [2]. However, even though TCFs can bind the c-fos SRE only in the presence of SRF, the knockout of SRF does not completely abolish c-fos induction [24]. This suggests a role for other c-fos promoter elements. We show that in Srf(-/-) ES cells, the residual response to serum is still PD98059- and Ro318220-sensitive (Figure 6), indicating SRF-independent signalling through the ERK cascade. It should be noted, however, that data with Ro318220 have to be treated with caution as it inhibits several kinases [30].
###end p 35
###begin p 36
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 57 66 57 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf(-/-) </italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 609 613 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 792 802 792 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 819 820 819 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
A possible mechanism for the residual c-fos induction in Srf(-/-) ES cells is activation of CREB bound to the c-fos CRE. Phosphorylation of CREB leading to transactivation has been shown to occur downstream of ERK1/ERK2 in response to mitogenic stimuli in a variety of cell types [12]. To examine a role for MSK1 in this process, we used ES cells lacking MSK1 [16]. Induction of c-fos in these cells was reduced by more than 50% as judged by quantitative RT-PCR as well as RNase protection (Figure 4 and unpublished results). Transfection of dominant negative CREB into fibroblasts has been shown to reduce c-fos induction to a similar extent [31]. Consistent with these results, we found that serum and LPA induce CREB phosphorylation in wild type cells, and that this is greatly reduced in Msk1(-/-) ES cells (Figure 5). Some CREB phosphorylation remains in the absence of MSK1, indicating that another CREB kinase exists in these cells. As MSK2 activity is undetectable in ES cells (unpublished results), the identity of this kinase remains unclear. Similarly, an undefined ERK-regulated CREB kinase distinct from MSK1 and MSK2 exists in fibroblasts [17].
###end p 36
###begin p 37
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 62 71 62 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf(-/-) </italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 431 435 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 465 475 465 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 569 578 569 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf(-/-) </italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1018 1022 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1265 1267 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1327 1331 1327 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1448 1452 1448 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1493 1497 1493 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
The interpretation of some of the residual c-fos induction in Srf(-/-) ES cells being due to CREB phosphorylation implies that the CRE is able to mediate c-fos activation in the absence of SRF. In the presence of SRF, CRE activation by mitogenic stimuli appears to be insufficient for c-fos activation, but requires co-operation of CREB and SRF [32]. Possibly, this requirement is relieved in cells lacking SRF. The reduction of c-fos induction by more than 50% in Msk1(-/-) ES cells being completely mediated by the CRE seems at odds with the 60-70% reduction seen in Srf(-/-) ES cells [24], where the effect should be due to a nonfunctional SRE. This may reflect interactions between the different promoter elements [4], with a lack of transactivation at the CRE reducing the effectiveness of the SRE. In addition, it may indicate multiple roles for MSK1. Another potential function for MSK1 is histone phosphorylation as part of the nucleosomal response [21]. MSK1 could therefore play a dual role by controlling c-fos at the level of chromatin remodelling as well as promoter activation. It was, however, not possible to examine this in ES cells due to the high level of mitosis-related histone phosphorylation in these cells that never become truly quiescent [24]. Also, to more directly evaluate the role of the CRE in c-fos regulation, it would be helpful to analyse the activation of reporter genes driven by a minimal CRE, the wild type c-fos promoter and mutant derivatives of the c-fos promoter in which particular promoter elements are inactivated. However, we failed to establish these assays in ES cells as we were unable to efficiently activate exogenously added reporter constructs.
###end p 37
###begin p 38
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
Besides MSK1, other kinases could act in a similar fashion. MAPKAP-K1/RSK also lies downstream of ERK1/ERK2, and it has been suggested to phosphorylate CREB [14], but see [15-17], and histone H3 [20], but see [21]. However, in MAPKAP-K1b/RSK2-deficient cells derived from Coffin-Lowry patients, serum-induced CREB phosphorylation and c-fos induction was normal [14]. This argues against a role of MAPKAP-K1/RSK in mediating the response to serum and also to LPA, which is a serum constituent.
###end p 38
###begin title 39
Conclusions
###end title 39
###begin p 40
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Our results show that MSK1 is an important ERK-activated mediator of mitogen-induced c-fos activation. In addition, they indicate that MSK1 may effect activation of the c-fos promoter by phosphorylating CRE binding proteins. To further delineate the mechanisms leading to immediate-early gene activation, the respective functions of the CREB kinase and the histone kinase activity of MSK isoforms need clarification.
###end p 40
###begin title 41
Methods
###end title 41
###begin title 42
Cell culture and stimulation
###end title 42
###begin p 43
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 154 163 154 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Srf(-/-) </italic>
###xml 167 177 167 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msk1(-/-) </italic>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 285 287 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 633 637 <span type="species:ncbi:9913">calf</span>
Mouse embryonic stem cells lacking SRF or MSK1 have been described previously [16,27]. Unless indicated otherwise, the knockout cell lines used were E100 Srf(-/-) and Msk1(-/-) No.4. Cells were cultured as described [24]. For stimulation experiments followed by quantitative RT-PCR, 105 cells were seeded on 3.5 cm gelatinised tissue culture plates, grown in complete medium for 24 h and incubated in serum-free medium as indicated in the figures. For most other experiments, cells were grown to confluence in complete medium, followed by incubation in serum-free medium as indicated in the figures. Cells were stimulated with fetal calf serum (Life Technologies) or LPA (Sigma) at final concentrations of 15% (v/v) and 20 muM, respectively. PD98059 and Ro318220 (Calbiochem) were used at final concentrations of 25 muM and 5 muM, respectively.
###end p 43
###begin title 44
Immunoblotting
###end title 44
###begin p 45
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
For analysis of MAP kinase and CREB phosphorylation, cells were lysed directly into SDS sample buffer [15], run on polyacrylamide gels and transferred onto nitrocellulose. Antibodies recognising phosphorylated ERK1/ERK2 (Thr202/Tyr204), JNK1/JNK2 (Thr183/Tyr185), p38 (Thr180/Tyr182), total ERK1/ERK2 or total p38 were from New England Biolabs. The antibody that recognises phospho-CREB (Ser133) and phospho-ATF1 (Ser63) was from Upstate. HRP-conjugated secondary antibodies were from Pierce, and detection was performed using the enhanced chemiluminescence reagent from Amersham.
###end p 45
###begin title 46
RT-PCR
###end title 46
###begin p 47
###xml 170 173 169 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">15 </sub>
###xml 406 408 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 692 696 690 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 684 689 <span type="species:ncbi:10090">mouse</span>
For quantitative RT-PCR, total RNA was isolated using the RNeasy kit (Qiagen) and treated with 10 U DNase I (Boehringer). 1 mug RNA was converted to cDNA using oligo-(dT)15 primers (MWG Biotech) and 200 U M-MLV Reverse Transcriptase (Promega). 1/50 of this reaction was included in each 10 mul PCR reaction. Quantitative PCR, data acquisition and calculation of relative mRNA levels was done as described [24]. Primers: c-fos forward CCTGCCCCTTCTCAACGAC, c-fos reverse GCTCCACGTTGCTGATGCT, hprt forward GCCTAAGATGAGCGCAAGTTG, hprt reverse TACTAGGCAGATGGCCAAAGG. For semi-quantitative RT-PCR, RNA was isolated as above and RT-PCR was done using the Access RT-PCR System (Promega) with mouse c-fos primers from Ambion.
###end p 47
###begin title 48
Immunoprecipitation kinase assays
###end title 48
###begin p 49
###xml 41 43 41 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
Cell lysates were prepared as described [17]. Protein concentrations of the lysates were determined by Bradford assay. Immunoprecipitation kinase assays were carried out as described [33] using an antibody that recognises residues 384-402 of MSK1 [15]. MSK1 was assayed after immunoprecipitation from 1 mg of cell lysate pre-cleared with protein G sepharose. One unit of activity was the amount that catalysed the phosphorylation of 1 nmole of the substrate GST-CREB in 1 min.
###end p 49
###begin title 50
Authors' contributions
###end title 50
###begin p 51
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
SS carried out the quantitative RT-PCR measurements (Figures 2A, 2C, 4A, 6), did the MAP kinase blots (Figures 1, 2B) and drafted the manuscript. AS did the semi-quantitative RT-PCR (Figure 4B), the RNA protection assays (not shown) and the phospho-CREB blots (Figure 5). GS participated in the quantitative RT-PCR measurements. JSCA did the MSK1 activity assays (Figure 3) and participated in the phospho-CREB blots. AN initiated and supervised this study. All authors read and approved the final manuscript.
###end p 51
###begin title 52
Acknowledgements
###end title 52
###begin p 53
We thank members of the Nordheim lab for discussion and advice. This work was funded by the DFG and the United Kingdom Medical Research Council through grants to AN (No 120/7-4) and JSCA. AS acknowledges support by the European TMR Cell Signalling Network.
###end p 53
###begin article-title 54
Development of our current understanding of bioactive lysophospholipids.
###end article-title 54
###begin article-title 55
Journey to the surface of the cell: Fos regulation and the SRE.
###end article-title 55
###begin article-title 56
MAPK-regulated transcription: a continuously variable gene switch?
###end article-title 56
###begin article-title 57
###xml 34 49 <span type="species:ncbi:10090">transgenic mice</span>
Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements.
###end article-title 57
###begin article-title 58
Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction.
###end article-title 58
###begin article-title 59
###xml 115 120 <span type="species:ncbi:9606">human</span>
The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter.
###end article-title 59
###begin article-title 60
The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF.
###end article-title 60
###begin article-title 61
SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation.
###end article-title 61
###begin article-title 62
A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity.
###end article-title 62
###begin article-title 63
MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo.
###end article-title 63
###begin article-title 64
Identification of multiple SRF N-terminal phosphorylation sites affecting DNA binding properties.
###end article-title 64
###begin article-title 65
CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.
###end article-title 65
###begin article-title 66
Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase.
###end article-title 66
###begin article-title 67
Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene.
###end article-title 67
###begin article-title 68
Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.
###end article-title 68
###begin article-title 69
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells.
###end article-title 69
###begin article-title 70
MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts.
###end article-title 70
###begin article-title 71
Independent dynamic regulation of histone phosphorylation and acetylation during immediate-early gene induction.
###end article-title 71
###begin article-title 72
Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation.
###end article-title 72
###begin article-title 73
Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3.
###end article-title 73
###begin article-title 74
The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase.
###end article-title 74
###begin article-title 75
The transcriptional coactivators p300 and CBP are histone acetyltransferases.
###end article-title 75
###begin article-title 76
Differential usage of signal transduction pathways defines two types of serum response factor target gene.
###end article-title 76
###begin article-title 77
Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells.
###end article-title 77
###begin article-title 78
PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.
###end article-title 78
###begin article-title 79
The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1beta (Rsk-2) and p70 S6 kinase.
###end article-title 79
###begin article-title 80
Srf(-/-) ES cells display non-cell-autonomous impairment in mesodermal differentiation.
###end article-title 80
###begin article-title 81
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability.
###end article-title 81
###begin article-title 82
Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation.
###end article-title 82
###begin article-title 83
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
###end article-title 83
###begin article-title 84
A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos.
###end article-title 84
###begin article-title 85
Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals.
###end article-title 85
###begin article-title 86
The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells.
###end article-title 86

